NeoGenomics (NEO) News
NASDAQ: NEOHealth CarePrecision InstrumentsUSD
16.35+0.33 (+2.06%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NEO news summary
We found 4 recent headlines mentioning NeoGenomics (NEO): 1 in the past week and 2 in the past 30 days, most often from Nasdaq, Investor's Business Daily. For price context, NEO is up 2.06% at $16.35. The most recent story, "Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive", was published by Investor's Business Daily on Oct 6, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest NeoGenomics headlines
- Stryker, Neogenomics Announce CEO Transitions; Both Stocks DiveStryker and Neogenomics stocks fell Tuesday after the medtech companies announced their chief executives would soon step down. The post Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive…Investor's Business DailyNEO, SYK
- Why Women-Run Companies Deserve a Place in Your PortfolioBMY, HALO, TGT, NEO and ROST stocks show how women-led companies are redefining growth with discipline, agility and results.NasdaqBMY, TGT, ROST, HALO
- Biotech Stocks At 52-Week Highs - NEO, BLSM, RVMD, ORMP, CADL(RTTNews) - The following biotech stocks reached a 52-week high on August 27, 2026, driven by key catalysts like various regulatory milestones.NasdaqBLSM, CADL, NEO, ORMP
- Noteworthy ETF Outflows: FBT, ONC, HALO, NEOLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol: FBT) where we…NasdaqFBT, ONC, HALO, NEO